Clinical Trials Directory

Trials / Completed

CompletedNCT02758496

A Chart Review to Evaluate the Safety and Efficacy of MeRT on Subjects With ASD

A Chart Review to Evaluate the Safety and Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) on Subjects With Autism Spectrum Disorder (ASD)

Status
Completed
Phase
Study type
Observational
Enrollment
141 (actual)
Sponsor
Wave Neuroscience · Industry
Sex
All
Age
2 Years – 20 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the safety and efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) on subjects with Autism Spectrum Disorder (ASD).

Detailed description

This is a retrospective chart review of 200 consecutive charts of subjects ages 2-20 years old seen at the Brain Treatment Center between 2010 and 2015. The review is designed to evaluate the safety and efficacy of Magnetic Electroencephalogram/Electrocardiogram(EEG/ECG)-Guided Resonance Therapy (MeRT) on subjects with Autism Spectrum Disorder (ASD).

Conditions

Interventions

TypeNameDescription
OTHERMeRT Efficacy Chart ReviewThere will be not intervention. This is a chart review.

Timeline

Start date
2016-04-01
Primary completion
2017-04-01
Completion
2017-04-01
First posted
2016-05-02
Last updated
2017-05-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02758496. Inclusion in this directory is not an endorsement.